Cargando…
FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
SIMPLE SUMMARY: FLT3-ITD monitoring is essential in AML management, and there is a great need for sensitive monitoring methods. We present a simple and easily applicable ITD-tracing algorithm optimized for MRD monitoring based on the NGS method. Our assay is sensitive to 0.001% and has a superior pe...
Autores principales: | Lee, Jong-Mi, Park, Silvia, Hwang, Insik, Kang, Dain, Cho, Byung Sik, Kim, Hee-Je, Ahn, Ari, Kim, Myungshin, Kim, Yonggoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776673/ https://www.ncbi.nlm.nih.gov/pubmed/36551616 http://dx.doi.org/10.3390/cancers14246121 |
Ejemplares similares
-
Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Kim, Hee-Je, et al.
Publicado: (2021) -
Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes
por: Kang, Dain, et al.
Publicado: (2022) -
Characteristics of DNMT3A mutations in acute myeloid leukemia
por: Park, Dong Jin, et al.
Publicado: (2020) -
Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications
por: Jung, Jin, et al.
Publicado: (2023) -
Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
por: Choi, Sujin, et al.
Publicado: (2020)